Toggle navigation
Home
Search
Services
Blog
Contact
About
Human Neurons in Vitro - Characterization of Receptors
Sah, Dinah W.
Signal Pharmaceuticals, LLC, San Diego, CA, United States
Search 3 grants from Dinah Sah
Search grants from Signal Pharmaceuticals, LLC
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Cleveland Precision Medicine Chronic Kidney Disease Cohort
Understanding the role of microglia on epileptogenesis
Treatment of ADHD in Pediatric Patients with Epilepsy
Expression and Function of Fmrp During Development
Alterations in Airway Mucin During Influenza Infection
Recently added grants:
Synthesizing Trial and Real-world Data on the Use of Biologics in Patients with Severe Asthma
A critical role for UBXN3B in IgG homeostasis and maternal transfer
N-methyl-D-aspartate receptors (NMDAr) participates in renal hemodynamic regulation and blood pressure homeostasis
Regulatory control of inflammatory cytokine production by a linear ubiquitin-binding protein
WT1 as an oncogene and therapeutic target in anaplastic Wilms tumor
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
2R42AG012576-02
Application #
2054257
Study Section
Special Emphasis Panel (ZRG2-BPO (01))
Project Start
1994-09-08
Project End
1998-02-28
Budget Start
1996-08-15
Budget End
1997-02-28
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Signal Pharmaceuticals, LLC
Department
Type
DUNS #
City
San Diego
State
CA
Country
United States
Zip Code
92121
Related projects
NIH 1997
R42 AG
Human Neurons in Vitro - Characterization of Receptors
Sah, Dinah W. / Signal Pharmaceuticals, LLC
NIH 1996
R42 AG
Human Neurons in Vitro - Characterization of Receptors
Sah, Dinah W. / Signal Pharmaceuticals, LLC
Comments
Be the first to comment on this grant